CLINICAL_TRIALS
trial_result
· 2014-01-10
Clinical Trial Update: Comparative Pharmacokinetic Study of Two Different Strengths of BAY14-2222 [Phase 1]
Summary
A Phase 1 pharmacokinetic study compared two strengths of BAY14-2222 in Hemophilia A and has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bayer | Conditions: Hemophilia A | Phase 1 | Status: COMPLETED